Preliminary experience with quality of life evaluation in patients with lung cancer.
AffiliationChristie Hospital and Holt Radium Institute, Manchester, UK.
MetadataShow full item record
AbstractEvaluating quality of life in patients receiving treatment for cancer has been an increasing concern, particularly when a cure may not be possible. Such measurements inform clinicians and investigators of the relative costs and benefits of palliative treatments, and are potentially important when there is little or no difference between drug regimens in terms of tumor response or survival. Where it is felt intuitively by oncologists that a particular mode or frequency of therapy may be superior to existing regimens, quality of life data may inform us differently, and there is a case to be made for incorporating such evaluations in clinical trials. In parallel to the experience of other groups, we have developed experience with certain scales, focusing on evaluations of lung cancer patients. This process enabled us to prospectively include and implement quality of life studies into our clinical trials.
CitationPreliminary experience with quality of life evaluation in patients with lung cancer. 1990, 4 (5):158-62; discussion 171 Oncology
- Measuring quality of life: an emerging science.
- Authors: Moinpour CM
- Issue date: 1994 Oct
- Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different?
- Authors: Hopwood P
- Issue date: 1996 Oct
- Drug development in patients with advanced non-small cell lung cancer and poor performance status.
- Authors: Stinchcombe TE, Socinski MA
- Issue date: 2004 Dec
- Quality of Life in elderly patients with cancer.
- Authors: Di Maio M, Perrone F
- Issue date: 2003 Sep 17
- [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
- Authors: Słowik-Gabryelska A, Szczepanik A, Kalicka A
- Issue date: 1999 Jan